scholarly journals Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study

2018 ◽  
Vol 68 (8) ◽  
pp. 1255-1264 ◽  
Author(s):  
Genovefa A Papanicolaou ◽  
Fernanda P Silveira ◽  
Amelia A Langston ◽  
Marcus R Pereira ◽  
Robin K Avery ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document